To investigate the potential downstream targets of KCNQ1OT1, the GEPIA database was browsed and MAP3K1, a crucial member of the MAPK signaling cascade, was found to be highly expressed in AML (Fig. S2). The gene discussed is MAP3K1; the disease is acute myeloid leukemia.